ABSTRACT 3-[5-{2-(2,3-Dihydroxyprop-1-yl)-o-carboran-1-yl}pentan-1-yl]thymidine (N5-2OH) is a first generation 3-carboranyl thymidine analog (3CTA) that has been intensively studied as a boron-10 ( 10 B) delivery agent for neutron capture therapy (NCT). N5-2OH is an excellent substrate of thymidine kinase 1 and its favorable biodistribution profile in rodents led to successful preclinical NCT of rats bearing intracerebral RG2 glioma. The present study explored cellular influx and efflux mechanisms of N5-2OH, as well as its intracellular anabolism beyond the monophosphate level. N5-2OH entered cultured human CCRF-CEM cells via passive diffusion, whereas the multidrug resistance-associated protein 4 appeared to be a major mediator of N5-2OH monophosphate efflux. N5-2OH was effectively monophosphorylated in cultured murine L929 [thymidine kinase 1 (TK1 1 )] cells whereas formation of N5-2OH monophosphate was markedly lower in L929 (TK1 -) cell variants. Further metabolism to the di-and triphosphate forms was not observed in any of the cell lines. Regardless of monophosphorylation, parental N5-2OH was the major intracellular component in both TK1
Introduction
A class of nucleoside bioconjugates designated as 3-carboranyl thymidine analogs (3CTAs) has been intensively studied in recent years as potential boron-delivery agents for neutron capture therapy (NCT). Presumably, these agents accumulate selectively in malignant cells by thymidine kinase 1 (TK1)-mediated trapping through 59-monophosphorylation (Khalil et al., 2013) . TK1 is a deoxynucleoside kinase that is primarily active during the S-phase of the cell cycle (Arnér and Eriksson, 1995) . The first generation 3CTA 3-[5-{2-(2,3-dihydroxyprop-1-yl)-o-carboran-1-yl}pentan-1-yl]thymidine (N5-2OH; Fig. 1 ) is an excellent substrate of TK1 and exhibits high uptake and retention in TK1-expressing tumor cells in vivo Barth et al., 2004 Barth et al., , 2008 . The favorable in vivo profile of N5-2OH led to successful preclinical NCT of rats bearing intracerebral RG2 glioma (Barth et al., 2008) . However, almost nothing is known about cellular influx and efflux mechanisms of N5-2OH or its intracellular anabolism beyond the monophosphate level. The purpose of the present study was to gain information on these aspects of cellular 3CTA metabolism and pharmacokinetics because they are important in assessing the basic clinical potential of these agents.
Many purine and pyrimidine nucleosides enter cells by mediated transport processes (Plunkett and Saunders, 1991) . Understanding transport mechanisms for nucleosides is important for evaluating clinical results because they have been implicated in resistance to nucleoside analog prodrugs, such as gemcitabine and capecitabine (Damaraju et al., 2003) . There are four members of the equilibrative nucleoside transporter family (hENT1/2/3/4) and three of the concentrative nucleoside transporter family (hCNT1/2/3) (Cass et al., 1998) . In addition, organic anion transporter (OAT) proteins mediate the exchange and transport of organic anions and show broad substrate selectivity including some cyclic nucleotides and antiviral nucleosides (Koepsell and Endou, 2004) . Upon entering cells, nucleosides are converted to triphosphates by a succession of cellular kinases before incorporation into nucleic acids by DNA polymerase. Monophosphorylation is carried out by nucleoside kinases (NKs), diphosphorylation by nucleoside monophosphate kinases (NMPKs), and triphosphorylation by nucleoside diphosphate kinase (NDPK) (Arnér and Eriksson, 1995; Parks and Agarwal, 1973; Kreimeyer et al., 2001; Eriksson et al., 2002; Pasti et al., 2003) . These phosphorylation steps are also critical in the activation of all biomedically relevant nucleoside analog prodrugs (Galmarini et al., 2001; Deville-Bonne et al., 2010) . Three members of the family of human multidrug resistance-associated proteins (MRP4/5/8) are able to transport nucleoside monophosphate analogs out of cells against concentration gradients. The presence of MRP4/5 is associated with resistance to several nucleoside analogs used in anticancer and antiviral therapies, including zidovudine (AZT), adefovir, ganciclovir, abacavir, and gemcitabine (Borst et al., 2004; Pastor-Anglada et al., 2005; Ritter et al., 2005) .
In the present study, we have investigated intracellular uptake and retention of N5-2OH and its metabolites in cultured human CCRF-CEM (TK1 1 ) and murine L929 (TK1 1 ) cells and their TK1-deficient variants. The impact of various cellular influx and/or efflux transporters [e.g., hENT1/2, hCNT1/2/3, organic cation transporters (OCTs), OATs, MRP4/5, P-glycoprotein (P-gp)] on cellular pharmacokinetics of N5-2OH and its metabolites was also explored. To study possible further metabolism of N5-2OH-monophosphate (MP), experiments with thymidine monophosphate kinase (TMPK), uridine monophosphate-cytidine monophosphate kinase (UMP-CMPK), and NDPK were performed. The capacity of Klenow DNA polymerase I to incorporate the triphosphate form of 3-[5-(o-carboran-1-yl)pentan-1-yl]thymidine (N5; Fig. 1 ), a 3CTA that is structurally related to N5-2OH (Khalil et al., 2013) , into oligonucleotide templates during processive DNA synthesis was also explored.
Materials and Methods
The synthesis of N5/N5-2OH and their phosphates ( (96-well) plates, cell culture media, horse serum, and fetal bovine serum (FBS) were from Gibco (Life Technologies, Grand Island, NY). Ecolite was from ICN Pharmaceuticals (Montreal, QC, Canada). The Cell Titer 96 Aqueous One Solution Cell Proliferation Assay Kit was from Promega (Madison, WI). Trypsin-EDTA and penicillin/streptomycin mixture (PeSt) were purchased from SVA (Uppsala, Sweden). Human recombinant TK1 and TMPK were prepared as described previously Carnrot et al., 2008) ; human recombinant cytosolic UMP-CMPK and human erythrocyte NDPK were purchased from OriGene Technologies Inc. (Rockville, MD) and Sigma-Aldrich, respectively. Light paraffin oil and silicone 550 oil were purchased from Sigma-Aldrich.
Cell Cultures and Preparation of Cell Extracts. Murine fibroblast cell lines, TK1 positive ATCC-CCL-34 (L929 TK1 1 ) and TK1 negative ATCC-CCL-1.3 (L929 TK1 -), and the human Tlymphoblast CCRF-CEM (ATCC-CCL-119) cell line (CEM TK1 1 ) were purchased from the American Type Culture Collection (ATCC, Manassas, VA). A subline of CCRF-CEM, deficient in thymidine kinase activity (CEM TK1 -), was originally provided by B. Ullman (Oregon State University, Corvallis, OR). Cell cultures were maintained according to ATCC recommendations and grown at 37°C in a humidified incubator in the presence of 5% CO 2 . L929 TK 1 cells were grown in Eagle's minimal essential medium supplemented with 10% horse serum, 2 mM L-glutamine and 1% PeSt. L929 TK -cells were grown in Dulbecco's modified Eagle's medium supplemented with 10% FBS, 4 mM L-glutamine, 1% PeSt; CCRF-CEM TK1 1 and TK1 -cells were grown as suspension cultures in RPMI 1640 with 10% FBS, 10 mM Hepes, 1 mM sodium pyruvate, and 1% PeSt. For uptake experiments CCRF-CEM and L929 cells were seeded at cell densities of 5 Â l0 5 cells/ml in growth media for 24 hours to ensure actively proliferating cells with population densities not exceeding 2 Â 10 6 cells/ml.
Metabolic Studies. Prior to metabolic assays, L929 cells were washed once in ice-cold phosphate-buffered saline (PBS) and resuspended in growth medium containing 10 mM 3 H-labeled nucleoside solution (1 part 3 H-labeled nucleoside and 9 parts cold nucleoside) of N5-2OH or thymidine (dThd). Following 2-hour jpet.aspetjournals.org incubation at 37°C in a humidified incubator in the presence of 5% CO 2 , medium was removed from L929 cells, and cells were washed with ice-cold PBS twice, trypsinized with 0.5% trypsin-EDTA for 5 minutes, and collected by centrifugation at 600g for 5 minutes at 4°C. After centrifugation, cell pellets were resuspended with 1 ml of PBS, cell numbers were determined, and cells were recentrifuged. Cell pellets were resuspended in 200 ml of 70% MeOH/30% 20 mM EDTA on ice, frozen in liquid nitrogen, and immediately sonicated (3 Â 1 minute) on ice. Supernatants were removed after centrifugation at 16,000g for 10 minutes at 4°C and frozen in dry ice, and MeOH/EDTA was evaporated by lyophilization. Samples were dissolved in the high-performance liquid chromatography (HPLC) mobile phase, and 200-ml aliquots were used for reversed-phase HPLC on a HPLC C18 column (250 Â 4.6 mm; ]dThd-DP levels in cell extracts were analyzed by DEAE-Sepharose chromatography. Cells were trypsinized with 0.5% trypsin-EDTA and centrifuged at 600g for 5 minutes. Cell pellets were resuspended in prechilled lysis buffer containing 10 mM Tris base, 50 mM NaCl, 1 mM MgCl 2 , 15 mM NaF, 10 mM dithiothreitol (DTT), 0.5% Nonidet P-40, and 10 mM EDTA and incubated on ice for 30 minutes. The cell extract was centrifuged twice at 16,000g for 10 minutes at 4°C. The supernatant was diluted with 0.5 M NH 4 HCO 3 to a final concentration of 0.5 mM and applied to DEAE-Sepharose. Table 2 ).
Nucleoside Transport in Saccharomyces cerevisiae. Yeast were separately transformed with plasmids (pYPhENT1, pYPhENT2, pYPhCNT1, pYPhCNT2, or pYPhCNT3) encoding hNTs (hENT1, hENT2, hCNT1, hCNT2, or hCNT3, respectively), as described elsewhere (Vickers et al., 2002; Zhang et al., 2003) . Thus, yeast genetically manipulated in this way expresses each of the five human nucleoside transporters. Uptake of 1 mM [ 3 H]Urd into yeast was measured, as previously described (Vickers et al., 2002; Zhang et al., 2003 Zhang et al., , 2005 , using the semiautomated cell harvester (Micro96 HARVESTER; Skatron Instruments, Lier, Norway). Yeast strains were maintained in complete minimal medium (CMM) containing 0.67% yeast nitrogen base amino acids (as required to maintain auxotrophic selection), and 2% glucose. Yeast cells were grown in CMM 2% glucose to an absorbance at 600 nm (A600 5 0.5-1.0), washed twice, and resuspended to A600 5 4.0. Yeast were incubated at ambient temperature with graded concentrations (0-1 mM) of N5-2OH in the presence of 1 mM [ 3 H]Urd in transport buffer (pH 7.4) containing 20 mM Tris, 3 mM K 2 HPO 4 , 1 mM MgCl 2 , 1.4 mM CaCl 2 , and 5 mM glucose with 144 mM NaCl. Yeast were also incubated with 1 mM Values from cultures without test compound were used to calculate the "% control." Urd self-inhibition was used as an internal control to define maximum inhibition of mediated transport. Transport reactions were initiated by rapid mixing of 50-ml yeast suspensions with or without graded concentrations of N5-2OH with 50 ml of 2 Â [ 3 H]nucleoside in 96-well microtiter plates. Yeast cells were collected on filter mats using a Micro96 Cell Harvester and rapidly washed with deionized water. Individual filter circles, corresponding to wells of the microtiter plates, were removed from filter mats with forceps and transferred to vials for quantification of radioactivity by scintillation counting.
Data were subjected to nonlinear regression analysis using GraphPad Prism software (version 4.03; GraphPad Software Inc., San Diego, CA) to obtain the concentration of test compound that inhibited growth of treated cells by 50% relative to that of untreated cells (IC 50 values). IC 50 values were determined from concentrationeffect curves. Each experiment was conducted with nine concentrations and six replicates per concentration and was repeated three times to obtain accurate IC 50 values ( Fig. 2A ; Table 1 ).
Nucleoside Transport Assays in CEM Cells. CCRF-CEM wildtype cells are known to only express hENT1 (Belt et al., 1993) . Inhibition of 1 mM [ 3 H]Urd uptake (30 seconds) was measured at ambient temperature in CEM cells in transport buffer (pH 7.4) containing 20 mM Tris, 3 mM K 2 HPO 4 , 1 mM MgCl 2 , 1.4 mM CaCl 2 , and 5 mM glucose with 144 mM NaCl in absence or presence of graded concentrations (0-0.5 mM) of N5-2OH. At the end of the uptake intervals, permeant-containing solutions were removed by aspiration, cells were spun down and quickly rinsed twice with transport buffer, and solubilized with 5% Triton X-100. Radioactivity in solubilized extracts was measured by liquid scintillation counting. Uptake values were expressed as picomoles per 10 6 cells and converted to %-control activity, and graphs were generated using GraphPad Prism. Each experiment was conducted three times with triplicate measurements for each condition (Figs. 2, B 3 H]Urd in absence or presence of either 100 mM dilazep (ENT inhibitor), 500 mM probenecid (OAT inhibitor), 500 mM cimetidine (OCT inhibitor), 100 mM N5-2OH, or 1 mM Urd for 1 minute, after which uptake was terminated by spinning cells though oil. Cells were washed by centrifugation and cell-associated radioactivity was determined by scintillation counting. Each experiment was conducted with six replicates per condition and was repeated three times with similar results (Fig. 3, C and D) .
Nucleoside uptake was measured at ambient temperature in actively proliferating cells (2 Â 10 6 cells/ml) using the oil-stop transport method (Harley et al., 1982) . CEM TK1 1 and CEM TK1 -cells were grown as described above. Cells were harvested by centrifugation (600g, 5 minutes), washed twice with PBS, and then resuspended in 100 ml of transport buffer (5 Â 10 6 cells). The time courses for initial rates of [ 3 H]N5-2OH uptake in CEM TK1 1 cells were determined using a rapid sampling procedure (10 seconds) that was initiated by addition of 100 ml of cells to 100 ml of [ 3 H]N5-2OH solution to a final concentration of 1 mM and terminated by the addition of 100 ml of 1 mM N5-2OH solution followed by centrifugation (16,000g, 30 seconds) through transport oil (Fig. 3A) . Cellular uptake of [ 1 and CEM TK1 -cells were determined at 30, 60, 90, and 120 minutes using the procedure described above. Final nucleoside concentrations were 1 mM and termination was accomplished by addition of 1 mM N5-2OH or dThd solutions followed by centrifugation through transport oil (Fig. 4) . Cell pellets were solubilized in 5% Triton X-100 and cell-associated radioactivity was determined by liquid scintillation counting.
The role of hENT1-mediated uptake of N5-2OH into CEM TK1 1 was studied in the presence of a range of concentrations of the hENT1 specific inhibitor NBMPR (0.1 and 1.0 mM). Cells were preincubated with inhibitors for 30 minutes, washed twice with PBS, and incubated with 1 mM [ 3 H]N5-2OH for 1 hour (Fig. 3A) . Uptake values were expressed as picomoles per 10 6 cells (Fig. 3A ) or % control (Fig. 4) , which is the mean counts per minute of cellassociated radioactivity compared with total counts per minute used for initiation of nucleoside transport (100%). Graphs were generated using GraphPad Prism. All experiments were performed in triplicates.
Cytotoxicity Assays. The Cell Titer 96 proliferation assay kit was used to quantify drug-induced cytotoxicity. Unless otherwise noted, CEM cells seeded in 96-well plates were exposed to graded concentrations (0-100 mM) of N5-2OH in the absence or presence of 1 mM NBMPR for 72 hours after which they were treated with 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) reagent for determination of cytotoxicity. IC 50 values were calculated from nonlinear regression analyses of values plotted as percentages of control values against the logarithm of drug concentrations (Fig. 3B ).
Efflux Studies. CCRF-CEM wild-type are known to express efflux pump proteins approximately in the following order: MRP4 . . MRP5 . P-gp (Peng et al., 2008) . For efflux studies CEM-TK1 1 cells (1 Â 10 6 per ml) were seeded in T75 flasks in growth media consisting of RPMI-1640 (without phenol red) with 10% FBS, 10 mM HEPES, 1 mM sodium pyruvate, and 1% PeSt and grown overnight. Cells were incubated for 1 hour with 1 mM [ 3 H]N5-2OH, washed twice in ice-cold PBS, and then incubated in growth medium without [ 3 H]N5-2OH for 150 minutes. To determine the amount of [ 3 H]N5-2OH-MP in cells at the beginning of efflux, a portion of the cell-containing mixture was taken immediately, cells were pelleted by centrifugation for 1 minutes at 12,000g, resulting cell pellets were solubilized by 5% Triton X-100, and radioactivity was determined by scintillation counting. The total counts per minute in 1-ml portions of cell-free medium was determined by scintillation counting at different time points. Levels of For efflux inhibition experiments, CEM-TK1 1 cells were incubated with 1 mM nucleoside mixture, composed of 0.1 mM radiolabeled [ 3 H]N5-2OH and 0.9 mM unlabeled N5-2OH, for 2 hours at 37°C in growth media as described above with either dipyridamole, indomethacin, or verapamil at a concentration of 100 mM. Cells were washed twice with ice-cold PBS, followed by addition of prewarmed media, and incubated for 2 hours at 37°C. Phosphate Transfer Assay. The adenosine 59-triphosphate transfer assay was performed with 0.05 mM [g2 32 P]ATP (10 mCi/ml), 100 mM ATP, 50 mM Tris-HCl (pH 7.6), 5 mM MgCl 2 , 100 mM KCl, 0.5 mg/ml bovine serum albumin (BSA), 10 mM DTT, and different concentrations of nucleoside analog. Reactions were initiated by adding either TK1, UMP-CMPK, TMPK, or NDPK followed by incubation at 37°C and termination by short boiling after different time points. Four microliters of reaction solutions were applied to polyethylenimine (PEI)-cellulose thin-layer chromatography (TLC) plates. Depending on the enzyme reaction, chromatography was performed with different buffers. For identification of nucleoside diphosphates, chromatography was performed with 0.2 M NaH 2 PO 4 buffer. Triphosphate products of thymidine triphosphate (dTTP) and N5-triphosphate (TP) from the NDPK assay were separated with 0.4 M NaH 2 PO 4 and 30% isopropanol. Phosphates were detected by autoradiography following 1-hour exposures of TLC plates to a phosphor imaging plate (BAS cassette 2040; Fujifilm, Tokyo, Japan) using the phosphorimaging system, Fuji BAS 2500/LAS 1000 (Fujifilm), in combination with an Image Reader V 1.7E (Supplemental Fig. 4; Fig. 5, A and B) .
Coupled Synthesis of dTTP and AZT Triphosphate. A coupled synthesis of dTTP and AZT triphosphate (AZT-TP) was performed using 200 mM of dThd or AZT with 0.05 mM [g2 32 P]ATP (10 mCi/ml) and 100 mM ATP in phosphate transfer assay buffer [50 mM Tris-HCl (pH 7.6), 5 mM MgCl 2 , 100 mM KCl, 0.5 mg/ml bovine serum albumin, 10 mM DTT]. The reaction was initiated by adding a mixture of recombinant human TK1 (100 ng), TMPK (100 ng), UMP-CMPK (100 ng), and NDPK (100 ng) followed by incubation at 37°C and termination by boiling after different time points. For separation of nucleoside monophosphates and diphosphates in the coupled reactions, chromatography was performed for 8-12 hours using isobutyric acid: NH 4 OH/H 2 O (66:1:33) (v/v) as the mobile phase. Products of the kinase reactions were detected by autoradiography as described above (Supplemental Fig. 5; Fig. 5, C and D) .
DNA Polymerase Running Start Assays. To prepare primer templates for running start reactions, the 16-mer primer 59-CGC CCA CGC GGC AGA G-39 (Invitrogen, Carlsbad, CA) was 59-end labeled with T4 polynucleotide kinase (as described in the manufacturer's procedure) and [g-32 P]ATP, desalted on a PD SpinTrap G-25 column (GE Healthcare, Pataskala, OH) in TEN buffer (10 mM Tris-Cl, pH 8.0, 1 mM EDTA, 100 mM NaCl), and annealed in a 1:2 ratio to the respective 36-mer templates 39-GCG GGT GCG CCT GCT CTT ACC TCT TCT CTC TTC TCT-59 (Invitrogen, Carlsbad, CA) in TEN buffer by heating to 75°C for 5 minutes followed by slow cooling to room temperature. Incorporation of triphosphates into the primer template was carried out in a volume of 20 ml for 45 minutes at 37°C with the 5-IU Klenow fragment of Escherichia coli DNA polymerase I (New England BioLabs Inc., Ipswich, MA), 0.25 pmol of labeled primer-template, and different concentrations of deoxynucleoside triphosphates. ]dThd were determined by addition of 100 ml of cells to 100 ml of labeled nucleoside solution to a final concentration of 1 mM and further processing as described in Materials and Methods. % Control is the mean counts per minute of cell-associated radioactivity compared with total counts per minute used for initiation of nucleoside transport (100%). Incorporation of triphosphates from coupled reactions into primer templates was carried out in final volumes of 20 ml by adding 5 ml of the original reaction product or 5 ml of diluted reaction product. Four dilution ratios (1/2, 1/4, 1/8, 1/16) were generated by adding appropriate quantities of reaction buffer to the original reaction product (Fig. 5, C (Belt et al., 1993) . Figure 2B shows effects of graded N5-2OH concentrations on 1 mM [ 3 H]Urd transport in CEM cells. These concentration-effect studies yielded IC 50 values of 36 6 5 mM for N5-2OH (Fig. 2B) for inhibition of hENT1-mediated Urd transport. Figure 2C shows effects of fixed concentrations of N5-2OH on Urd transport rates. Data were analyzed using Lineweaver-Burk plot, which shows competitive inhibition of Urd transport by N5-2OH. Further analysis by Dixon plot gave a K i value of 22 6 1.6 mM.
Effects of Inhibitors Fig. 3A . Uptake appeared to be linear and the presence of either 0.1 mM or 1 mM NBMPR had no effect on initial rates, i.e., 1.33 6 0.26 mol/s per 10 6 cells (without NBMPR) compared with 1.21 6 0.28 mol/s per 10 6 cells with NBMPR (Fig. 3A) . Results of cytotoxicity studies with NBMPR were consistent with the lack of effect on initial rates of uptake in that exposures to graded concentrations (0-100 mM) of N5-2OH in the absence or presence of NBMPR (1 mM) for 72 hours yielded similar results (Fig. 3B) .
Uptake of 1 mM [ 3 H]N5-2OH or 1 mM [ 3 H]Urd into CEM cells was measured in the absence or presence of either 100 mM dilazep (ENT inhibitor), 500 mM probenecid (OAT inhibitor), 500 mM cimetidine (OCT inhibitor), 100 mM N5-2OH, or 1 mM Urd. Results obtained with N5-2OH (Fig.  3C ) demonstrated minimal inhibition of uptake by dilazep, probenecid, cimetidine, or excess Urd. In contrast, Urd uptake (Fig. 3D) Figs. 1 and 2) . The uptake mechanism of N5-2OH by CEM TK1
1 and TK1 -cells, both at long and short periods of incubation, was investigated. The time course of cellular uptake and metabolism of [ 3 H]N5-2OH was followed for up to 120 minutes, as described in Materials and Methods. Uptake and retention of dThd and N5-2OH (and their metabolites) reached steady-state levels after 60 minutes of incubation in both CEM TK1
1 and CEM TK1 -cells (Fig. 4 ). Levels of [ 3 H]dThd in TK1 -cells were more than 10-fold lower than that in TK1 1 cells (Fig. 4A ), whereas the difference in [
3 H]N5-2OH levels between cell lines was less pronounced (Fig. 4B) 1 cells were 4.6 6 0.5 and 1.5 6 0.12 pmol/10 6 cells, respectively ( (Table 2) .
A control experiment was performed with [ 3 H]dThd, i.e., a 2-hour labeling period followed by 24 hours incubation in compound-free medium and, in this case, 9.6% of total counts per minute was retained in L929 TK1 1 cells and 0.3% of total counts per minute in L929 TK1 -cells (data not shown). Intracellular concentrations of dThd, dTMP, and dTDP in L929 TK1 1 were 1.5 6 0.16, 5.8 6 0.56, and 0.5 6 0.03 pmol/ 10 6 cells, respectively, and 1.4 6 0.09, 0.039 6 0.004, and 0 pmol/10 6 cells, respectively, in L929 TK1 -cells (Table 2 ). The obtained data showed that N5-2OH could be taken up and retained in a TK1-independent fashion in two pairs of TK1-positive and -negative cell lines. In the case of L929 TK1 1 cells, [
H]N5-2OH-MP was retained significantly longer than in L929 TK1
-cells, indicating that formation of N5-2OH-MP was catalyzed by TK1. There was no indication for further phosphorylation of this metabolite in L929 cells (Supplemental Figs. 1 and 2 ).
Phosphorylation Studies with N5 and N5-2OH Monophosphates Using Recombinant Kinases. It is well established that N5, N5-2OH, and numerous other 3CTAs are good substrates of TK1 (Khalil et al., 2013) . To study the further anabolism of N5 and N5-2OH, a series of experiments with human nucleoside mono-and diphosphate kinases were performed using appropriate phosphorylated substrates. Two Cellular Influx, Efflux, and Anabolism of 3CTAs recombinant human pyrimidine nucleoside monophosphate kinases, UMP-CMPK and TMPK, were tested for their capacity to phosphorylate N5-and N5-2OH-MP. Monophosphates and diphosphates (DP) of N5 and N5-2OH (Fig. 1) were synthesized as described in Supplemental Schemes 1 and 2. N5-MP and N5-DP were used in these studies as surrogate systems for the corresponding phosphates of N5-2OH because of anticipated stability issues during synthesis of the latter ones, in particular N5-2OH-diphosphate (DP) (Supplemental Data). This approach was warranted since N5 and N5-2OH appeared to have generally similar enzymatic properties .
Both recombinant UMP-CMPK and TMPK showed high activities with their endogenous substrates dCMP and dTMP, whereas N5-MP or N5-2OH-MP substrates did not produce detectable amounts of diphosphate products (Fig. 5A ), even at extended reaction times (Supplemental Fig. 4 ). Computational docking studies reinforced our experimental finding that N5-2OH-MP is not a substrate for TMPK (Supplemental Fig. 3) . Docking of dTMP into the crystal structure of TMPK reproduced the pose of cocrystallized dTMP accurately [lowest root mean squared deviation (RMSD) 5 1.03 Å], whereas N5-2OH-MP docked in marked distance to the original dTMP binding site (lowest RMSD 5 6.43 Å).
It was demonstrated by TLC that human NDPK phosphorylated N5-DP to N5-TP with a phosphorylation efficiency of approximately 30% relative to that of dTDP (Fig. 5B) . Increasing the reaction time from 30 to 60 minutes led to an increase of N5-TP formation by a factor of 2, whereas the rate of dTTP formation using dTDP as the substrate remained unchanged, indicating a substantially lower efficiency of N5-DP to serve as substrate for NDPK.
DNA Incorporation Studies. The capacity of the Klenow DNA polymerase I enzyme to incorporate N5-TP, AZT-TP, and dTTP into oligonucleotide templates during processive DNA synthesis, i.e., using running start primer-templates, was investigated (Copeland et al., 1992; Eriksson et al., 1995) . For these studies we used a coupled synthesis of dTTP and AZT-TP by adding a mixture of recombinant human TK1, TMPK, UMP-CMPK, and NDPK to either dThd or AZT. For the synthesis of N5-TP we used N5-DP as a substrate for NDPK as described above. As a control for each enzyme step, we carried out a series of assays using only TK1 or combinations of TK1 with TMPK or UMP-CMPK. A TLC analysis of mono-and diphosphate products in the enzyme reactions with dThd and AZT is shown in Supplemental Fig. 5 . The running start primer reaction was performed as described in Materials and Methods, and a gel analysis of the reaction products with Klenow DNA polymerase I and dTTP, AZT-TP, and N5-TP using a running start primer-template DNA is shown Fig. 5 , C and D. Incubation of the 16-mer primer template with T4 polynucleotide kinase and [g2 32 P]ATP led to 32 Pilabeled 18-mer nucleotide product. Both dTTP and coupled synthesis dTTP product were incorporated by Klenow DNA polymerase I into the running start primer with the formation of 32 Pi-labeled 19-mer nucleotide products. The coupled synthesis AZT-TP product was also a substrate for Klenow DNA polymerase I, whereas N5-TP apparently was not, since no incorporation of N5-TP into the oligonucleotide was detected (Fig. 5D) . (Fig. 6B) .
Removing [ 3 H]N5-2OH from the media led to a rapid loss of labeled nucleoside from the cells. There was decrease in radioactivity (~30%) 60 minutes after the transfer of cells to nucleoside-free media. Following this, radioactivity levels reached a plateau (Fig. 6A) We also studied effects of specific efflux inhibitors-e.g., dipyridamole, indomethacin and verapamil-on extracellular N5-2OH-MP levels (Fig. 6C) . Results showed that dipyridamole, an inhibitor of MRP4 and MRP5 (Ritter et al., 2005) , and indomethacin, a relatively selective inhibitor of MRP4 (Ritter et al., 2005) , decreased the efflux of N5-2OH-MP by approximately 80%. Verapamil, an inhibitor of P-gp (Summers et al., 2004) , decreased efflux of N5-2OH-MP from CEM TK 1 cells only by approximately 30%.
Discussion
Data from earlier studies suggested that phosphorylation by TK1 was required for uptake and retention of the N5-2OH in malignant cells both in vitro and in vivo (Al-Madhoun et al., 2004; Barth et al., 2004 Barth et al., , 2008 . However, little information is available regarding the complete intracellular metabolism of N5-2OH, including its potential incorporation into DNA. In addition, mechanisms of cellular membrane traversal of N5-2OH and its metabolites are largely unexplored. Only hENT1-mediated Urd transport was inhibited by N5-2OH, both in yeast and CEM cells. In experiments with CEM cells, Urd uptake inhibition by N5-2OH was shown to be competitive. However, the high affinity hENT1 transport inhibitor NBMPR had minimal effects on uptake of N5-2OH, suggesting that hENT1 played no major role in the uptake of N5-2OH by CEM cells. Furthermore, the cytotoxicity of N5-2OH for CEM cells in the presence of 1 mM NBMPR was the same as in its absence, thus confirming that hENT1 was not important in mediating uptake of N5-2OH into CEM cells.
Uptake of 1 mM [ 3 H]N5-2OH into CEM cells was further evaluated in presence or absence of several transport inhibitors, including dilazep, NBMPR, probenecid, and cimetidine as well as excess nonradioactive Urd and N5-2OH. Excess nonradioactive N5-2OH inhibited [ 3 H]N5-2OH uptake to a low extent, suggesting the possible presence of an unidentified uptake mechanism. All other transport inhibitors had little or no effect on uptake of [ 3 H]N5-2OH into cells. In contrast, [ 3 H]Urd uptake in CEM cells was inhibited by both dilazep and excess Urd, which is consistent with mediated uptake by hENT1, a transporter known to be selectively expressed in CEM cells (Belt et al., 1993 To substantiate the metabolic profile found for N5-2OH in cell culture experiments, a series of experiments with recombinant human pyrimidine nucleoside monophosphate kinases, UMP-CMPK and TMPK, were performed to test their capacity to phosphorylate N5-MP and N5-2OH-MP. Both monophosphate kinases showed high activity with their endogenous substrates dCMP and dTMP, respectively. In contrast, when N5-MP and N5-2OH-MP were used as substrates, no diphosphate products were observed. This finding correlated with the metabolite analysis of N5-2OH in our cell culture studies. Surprisingly, however, human NDPK did catalyze the phosphorylation of N5-DP to N5-TP although with a substantially lower efficiency compared with endogenous dTDP.
Both efficacy as boron delivery agents for NCT and cytotoxicity of 3CTAs may be related to their potential incorporation into DNA, as has been discussed by us previously Tjarks et al., 2007) . Thus, we studied the capacity of Klenow DNA polymerase I to incorporate N5-TP, AZT-TP, and dTTP into oligonucleotide templates during processive DNA synthesis, i.e., using a running start primer-template system. Both AZ-TP and dTTP, generated via coupled enzymatic synthesis, were good substrates for Klenow DNA polymerase I. In contrast, N5-TP, synthesized enzymatically from NDPK/N5-DP, apparently was not incorporated into template oligonucleotide by this polymerase. This result is consistent with data from a previous study indicating that 3-methyl-dTTP could not be incorporated into DNA (Huff and Topal, 1987) . The apparent lack of DNA incorporation of N5-TP supports the moderate in vitro and in vivo toxicity observed for 3CTAs (see also Fig. 3B ) Barth et al., 2004 Barth et al., , 2008 . On the other hand, the absence of DNA incorporation did not appear to hamper the efficacy of N5-2OH in preclinical NCT studies, as previously reported (Barth et al., 2008) .
Our studies indicated that N5-2OH-MP was subject to cellular efflux from CCRF-CEM wild-type cells and that both dipyridamole and indomethacin inhibited the efflux of N5-2OH-MP, whereas verapamil had minimal effects on N5-2OH-MP efflux. Previous studies have shown that MRP4 is a major efflux pump in CCRF-CEM wild-type cells (Peng et al., 2008) . Thus, the strong inhibition of N5-2OH-MP efflux by the selective MRP4 inhibitor indomethacin suggests a key role for this pump as a regulator of the intracellular accumulation of N5-2OH-MP.
In conclusion, N5-2OH traverses cell membranes via passive diffusion and its monophosphate appears to be a substrate of MRP4 in CCRF-CEM wild-type cells. In addition, 3CTAs, such as N5 and N5-2OH, appear to possess a unique metabolic profile among established biomedical/clinical nucleoside analogs because they are metabolized exclusively by TK1 within the range of enzymes that can bind the dThd scaffold intracellularly. Previous studies have shown that N5-2OH is not a substrate of thymidine kinase 2 (TK2) and catabolizing thymidine phosphorylase (TPase) and deoxynucleotidase-1 (dNT-1) did not catalyze dephosphorylation of N5-2OH-MP Tjarks et al., 2007) . Chemical shifts (δ) are reported in ppm from internal deuterated chloroform or methanol.
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Coupling constants are reported in Hz. as well as compounds 5 ) and 6 (Davisson et al., 1987 ) (see below) were synthesized as described previously. HPLC retention times for N5
(Method B), N5-2OH (Method C), and N5-2OH-MP (Method C) were 33.04, 16.45 and 13.87, respectively.
S.1.3.2. Synthesis of N5-MP
Scheme S1: Synthesis of N5-monophosphate S.1.3.2.1. 5'-Bis(2,2,2-trichloroethyl) ester of N5 (2).
A mixture of N5 (compound 1, 340 mg, 0.75 mmol), bis(2,2,2-trichoroethyl) phosphorochloridate (330 mg, 0.87 mmol), anhydrous pyridine (50 µL, 1.04 mmol) in 10 ml of S7 acetonitrile was stirred at 0°C for 5 days. The reaction was quenched by adding 5 ml of MeOH and stirred for additional 30 min at room temperature. Following solvent evaporation, the residue was extracted with 20 ml of diethylether and washed with 10 ml of 0.1 M HCl. The organic layer was dried over MgSO 4 , filtered, and evaporated. The residue was purified by silica gel column chromatography using hexanes: ethyl acetate (9:1) to give compound 2 (0.27 g, 45% 164.53, 151.45, 135.57, 110.41, 95.26, 86.90, 85.32, 77.77, 76.53, 71.00, 69.34, 62.88, 41.25, 39.82, 37.83, 29.24, 27.27, 26.45, 12.66 
S.1.3.2.2. Disodium salt of the 5'-monophosphate of N5 (3).
To a solution of 20 mg (0.31 mmol) of zinc powder in 10 ml of acetic acid, compound 2 (30 mg, 0.04 mmol) was added and the resulting suspension was stirred for 10 h. The reaction mixture was filtered and evaporated. The residue was purified by HPLC (Method A) and the desired compound was passed through a column containing Amberlite 200 (sodium form) to furnish the disodium salt of the 5'-monophosphates of N5 (3, 8.5 mg, 39% 165.50, 152.38, 136.70, 111.14, 88.04, 87.14, 77.27, 73.17, 63.62, 61.96, 41.89, 38.56, 30.73, 29.95, 27.96, 27.15, 13.43 To a solution of compound 4 (0.3 g, 0.6 mmol) in THF (30 ml) was added a 1 M solution of TBAF (0.9 ml, 0.9 mmol) in THF at -78ºC. The reaction mixture was stirred at room temperature for 1 h. Distilled water (10 ml) was added and excess THF was removed under reduced pressure.
The residue was extracted with ethyl acetate, the combined organic layers were washed with brine, dried over anhydrous MgSO 4 , and filtered. The residue was purified by silica gel column chromatography using hexanes: ethyl acetate (8:2) to give compound 5 (158 mg, 69% 145. 07, 133.07, 130.05, 127.99, 75.04, 69.96, 61.24, 37.84, 28.60, 28.43, 24.96, 21 .80.
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S.1.3.3.2. 3-(o-Carboranylpentyl)-5'-tosyl-thymidine (7).
A mixture of compound 5 (130 mg, 0.34 mmol), compound 6 (122 mg, 0.31 mmol), and K 2 CO 3 (85 mg, 0.62 mmol) in 10 ml of DMF/acetone (50/50) was stirred for 2 days at 50°C. The solvent was evaporated and the residue was purified by silica gel column chromatography using DCM: acetone (85: 15) to give compound 7 (50 mg, 27% 132.34, 130.34, 127.98, 110.95, 85.43, 83.70, 75.39, 71.42, 68.85, 61.13, 41.04, 40.50, 37.92, 28.82, 27.07, 26.26, 21.86, 13.33 To a solution of compound 7 (10 mg, 0.016 mmol) in anhydrous CH 3 CN (16 µL, 1M), tris(tetra-n-butylammonium) hydrogen pyrophosphate (22 mg, 0.24 mmol) was added. The mixture was stirred for 2 days and methanol (0.5 ml) was added. Following filtration, the 165. 58, 152.43, 136.46, 111.15, 87.57, 86.91, 72.03, 66.38, 66.34, 60.05, 42.48, 40.76, 32. and Mg 2+ was used for docking. N5-2OH was constructed as described previously (Tiwari et al. 2009 ). N5-2OH-MP was prepared by adding a phosphate group to 5'-OH of N5-2OH using
Sybyl. N5-2OH-MP was aligned to co-crystalized dTMP prior to docking. The protein structure in mol2 format was prepared with the structure preparation tool of Sybyl. The blocking groups AMI and CXC were added to the N-and C-termini, respectively, for neutralization. Water molecules were removed, hydrogen atoms were added, and side chain amides and side chain bumps were fixed. Both dTMP and ADP were deleted from the crystal structure prior to docking.
For docking, the protomol file was generated using the "none" command from the protein mol2
file. Docking was carried out with Surflex using the default method. The root-mean-square deviations (RMSDs) of the docked poses were obtained using the "rms" command. For the calculation of the RMSD of N52OH-MP, only the dThd scaffold was considered using cocrystalized dTMP as a reference molecule. S14 S.4. Autoradiographic studies Figure S4 . Autoradiogram of a TLC analysis of diphosphate products in TMPK enzyme reactions with dTMP, N5-MP, and N5-2OH-MP.
The assays were performed for 20, 40, and 60 min, as described in Materials and Methods.
Products of the enzyme reactions were separated by TLC using a running buffer of 0.2 M Na H 2 PO 4 .
Additional comments: Several sets of experiments were carried out with reaction times ranging from 20 and 60 min. No diphosphate products of N5 and N5-2OH were generated. Additional comments: As a control for the coupled synthesis for each enzyme step, assays were carried out using either TK1 alone or combinations of TK1 with TMPK or UMP-CMPK.
An autoradiogram of a TLC analysis of mono and diphosphate products for enzyme reactions with dThd and AZT is shown in Fig. S5 . dTMP and AZT-MP are not substrates for UMP-CMPK and only one monophosphate product with TK1 and UMP-CMPK was observed. However, dTMP and AZT-MP are good substrates for TMPK resulting in the formation of dTDP and AZT-DP, respectively, using the TK1/TMPK combination (Fig. S5 ). 
